𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 gene mutations in pediatric brain tumors

✍ Scribed by Felix, Carolyn A. ;Slavc, Irene ;Dunn, Michael ;Strauss, Eric A. ;Phillips, Peter C. ;Rorke, Lucy B. ;Sutton, Leslie ;Bunin, Greta R. ;Biegel, Jaclyn A.


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
796 KB
Volume
25
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We investigated the frequency of p53 mutations in 47 pediatric brain tumors of various histologic subtypes that were collected over a period of 5 years. The specimens included 15 primitive neuroectodermal tumors (PNETs), 17 low grade astrocytomas, one anaplastic astrocytoma, three glioblastomas (GBMs), one mixed glial tumor, eight ependymomas, one choroid plexus carcinoma, and one gangliocytoma/ganglioneuroma. Mutations were identified by single strand conformation polymorphism analysis of exons 4–8 and verified by sequencing. Mutations were present in 2 of 3 cases of GBM, but not in 17 low grade astrocytomas (P = 0.02, Fisher's exact test). One GBM demonstrated a germline GGC to AGC transition (gly to ser) at codon 245 with loss of the wild‐type allele. A second GBM contained a CGG to TGG transition (arg to trp) at codon 248, also with loss of the wildtype allele, but normal tissue was not available for comparison. In addition, one of 15 PNETs retained heterozygosity but demonstrated a somatic CGT to TGT transition (arg to cys) at codon 273. p53 mutations were absent in other histologic subtypes and in two cases with multiple primary cancers. These data are consistent with earlier findings that p53 mutations are rare in PNETs, which are primarily pediatric tumors. In contrast to adult gliomas, p53 mutations in pediatric gliomas appear restricted to the GBMs. The lack of p53 mutations in pediatric low grade astrocytomas suggests not only histological differences, but also a different molecular pathogenesis in adult and pediatric patients. Β© 1995 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Mutations of p53 tumor-suppressor gene i
✍ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 50 KB πŸ‘ 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

p53 Mutations in sporadic adrenocortical
✍ H. Ohgaki; P. Kleihues; P. U. Heitz πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 502 KB

Non-familial human adrenocortical adenomas and carcinomas were screened for mutations in exons 5-8 of the p53 tumor suppressor gene by single-strand-conformation-polymorphism (SSCP) analysis, followed by direct sequencing of PCR-amplified DNA. Point mutations in codons 12, 13 and 61 in H-ras, K-ras

P53 tumor suppressor gene mutations in h
✍ Sanjay Katiyar; Bipin C. Dash; Varsha Thakur; Raj C. Guptan; Shiv K. Sarin; Bhud πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 3 views

BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and

p53 mutations in human tumors with chime
✍ Richard Hamelin; Jessica Zucman; Thomas Melot; Olivier Delatre; Gilles Thomas πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 549 KB

Mutations iin these DNA samples have already been reported under different coded numbers (Hamelin et al., 1993).-?The deleted sequence is GGTTGCCCAGGGT starting at the 34th bp of intron 5. It does not include known important consensus sequences for splicing.-"xon number. -"he number of alleles is d